Vitamin D and Colon Cancer

World Journal of Gastrointestinal Oncology

Volumn 6, Issue 11, 2014, Pages 430-437

  Klampfer, Lidija ^a  

^a SOUTHERN RESEARCH INSTITUTE   (United States)

Author keywords

Chemoprevention; Colon cancer; Inflammation; Vitamin D; Wnt signaling

Indexed keywords

EID: 84937637025     PISSN: None     EISSN: 19485204     Source Type: Journal    
DOI: 10.4251/wjgo.v6.i11.430     Document Type: Article

References (71)

1. 1 Deeb KK, Trump DL, Johnson CS. Vitamin D signalling pathways in cancer: potential for anticancer therapeutics. Nat Rev Cancer 2007; 7: 684-700 [PMID: 17721433 DOI: 10.1038/ nrc2196]
2. 2 Anderson MG, Nakane M, Ruan X, Kroeger PE, Wu-Wong JR. Expression of VDR and CYP24A1 mRNA in human tu¬mors. Cancer Chemother Pharmacol 2006; 57: 234-240 [PMID: 16180015 DOI: 10.1007/s00280-005-0059-7]
3. 3 Palmer HG, Gonzalez-Sancho JM, Espada J, Berciano MT, Puig I, Baulida J, Quintanilla M, Cano A, de Herreros AG, Lafarga M, Munoz A. Vitamin D(3) promotes the differentia¬tion of colon carcinoma cells by the induction of E-cadherin and the inhibition of beta-catenin signaling. J Cell Biol 2001; 154: 369-387 [PMID: 11470825 DOI: 10.1083/jcb.200102028]
4. 4 Kumagai T, O'Kelly J, Said JW, Koeffler HP. Vitamin D2 analog 19-nor-1,25-dihydroxyvitamin D2: antitumor activ¬ity against leukemia, myeloma, and colon cancer cells. J Natl Cancer Inst 2003; 95: 896-905 [PMID: 12813173]
5. 5 Palmer HG, Larriba MJ, Garcia JM, Ordonez-Moran P, Pena C, Peiro S, Puig I, Rodriguez R, de la Fuente R, Bernad A, Pollan M, Bonilla F, Gamallo C, de Herreros AG, Munoz A. The transcription factor SNAIL represses vitamin D recep¬tor expression and responsiveness in human colon cancer. Nat Med 2004; 10: 917-919 [PMID: 15322538 DOI: 10.1038/ nm1095]
6. 6 Salehi-Tabar R, Nguyen-Yamamoto L, Tavera-Mendoza LE, Quail T, Dimitrov V, An BS, Glass L, Goltzman D, White JH. Vitamin D receptor as a master regulator of the c-MYC/MXD1 network. Proc Natl Acad Sci USA 2012; 109: 18827-18832 [PMID: 23112173 DOI: 10.1073/pnas.1210037109]
7. 7 Nurnberg B, Graber S, Gartner B, Geisel J, Pfohler C, Schadendorf D, Tilgen W, Reichrath J. Reduced serum 25-hydroxyvitamin D levels in stage IV melanoma patients. Anticancer Res 2009; 29: 3669-3674 [PMID: 19667163]
8. 8 Feldman D, Krishnan AV, Swami S, Giovannucci E, Feld¬man BJ. The role of vitamin D in reducing cancer risk and progression. Nat Rev Cancer 2014; 14: 342-357 [PMID: 24705652 DOI: 10.1038/nrc3691]
9. 9 Milczarek M, Psurski M, Kutner A, Wietrzyk J. Vitamin D analogs enhance the anticancer activity of 5-fluorouracil in an in vivo mouse colon cancer model. BMC Cancer 2013; 13: 294 [PMID: 23777514 DOI: 10.1186/1471-2407-13-294]
10. 10 Milczarek M, Rosinska S, Psurski M, Maciejewska M, Kut- ner A, Wietrzyk J. Combined colonic cancer treatment with vitamin D analogs and irinotecan or oxaliplatin. Anticancer Res 2013; 33: 433-444 [PMID: 23393334]
11. 11 Moon M, Song H, Hong HJ, Nam DW, Cha MY, Oh MS, Yu J, Ryu H, Mook-Jung I. Vitamin D-binding protein interacts with Ap and suppresses Ap-mediated pathology. Cell Death Differ 2013; 20: 630-638 [PMID: 23257976 DOI: 10.1038/ cdd.2012.161]
12. 12 Jacobs ET, Hibler EA, Lance P, Sardo CL, Jurutka PW. Asso¬ciation between circulating concentrations of 25(OH)D and colorectal adenoma: a pooled analysis. Int J Cancer 2013; 133: 2980-2988 [PMID: 23754630 DOI: 10.1002/ijc.28316]
13. 13 Gandini S, Boniol M, Haukka J, Byrnes G, Cox B, Sneyd MJ, Mullie P, Autier P. Meta-analysis of observational studies of serum 25-hydroxyvitamin D levels and colorectal, breast and prostate cancer and colorectal adenoma. Int J Cancer 2011; 128: 1414-1424 [PMID: 20473927 DOI: 10.1002/ijc.25439]
14. 14 Garland CF, Comstock GW, Garland FC, Helsing KJ, Shaw EK, Gorham ED. Serum 25-hydroxyvitamin D and colon can-cer: eight-year prospective study. Lancet 1989; 2: 1176-1178 [PMID: 2572900]
15. 15 Kampman E, Slattery ML, Caan B, Potter JD. Calcium, vita¬min D, sunshine exposure, dairy products and colon cancer risk (United States). Cancer Causes Control 2000; 11: 459-466 [PMID: 10877339]
16. 16 Newmark HL, Lipkin M. Calcium, vitamin D, and colon cancer. Cancer Res 1992; 52: 2067s-2070s [PMID: 1544142]
17. 17 Robsahm TE, Tretli S, Dahlback A, Moan J. Vitamin D3 from sunlight may improve the prognosis of breast-, colon- and prostate cancer (Norway). Cancer Causes Control 2004; 15: 149-158 [PMID: 15017127]
18. 18 Kremer R, Campbell PP, Reinhardt T, Gilsanz V. Vitamin D status and its relationship to body fat, final height, and peak bone mass in young women. J Clin Endocrinol Metab 2009; 94: 67-73 [PMID: 18984659]
19. 19 Gorham ED, Garland CF, Garland FC, Grant WB, Mohr SB, Lipkin M, Newmark HL, Giovannucci E, Wei M, Holick MF. Vitamin D and prevention of colorectal cancer. J Steroid Bio- chem Mol Biol 2005; 97: 179-194 [PMID: 16236494]
20. 20 Grau MV, Baron JA, Sandler RS, Haile RW, Beach ML, Church TR, Heber D. Vitamin D, calcium supplementation, and colorectal adenomas: results of a randomized trial. J Natl Cancer Inst 2003; 95: 1765-1771 [PMID: 14652238]
21. 21 Ng K, Meyerhardt JA, Wu K, Feskanich D, Hollis BW, Giovannucci EL, Fuchs CS. Circulating 25-hydroxyvitamin d levels and survival in patients with colorectal cancer. J Clin Oncol 2008; 26: 2984-2991 [PMID: 18565885 DOI: 10.1200/ JCO.2007.15.1027]
22. 22 Freedman DM, Looker AC, Chang SC, Graubard BI. Pro¬spective study of serum vitamin D and cancer mortality in the United States. J Natl Cancer Inst 2007; 99: 1594-1602 [PMID: 17971526 DOI: 10.1093/jnci/djm204]
23. 23 Newmark HL, Yang K, Kurihara N, Fan K, Augenlicht LH, Lipkin M. Western-style diet-induced colonic tumors and their modulation by calcium and vitamin D in C57Bl/ 6 mice: a preclinical model for human sporadic colon cancer. Carci¬nogenesis 2009; 30: 88-92 [PMID: 19017685 DOI: 10.1093/car- cin/bgn229]
24. 24 Yang K, Kurihara N, Fan K, Newmark H, Rigas B, Bancroft L, Corner G, Livote E, Lesser M, Edelmann W, Velcich A, Lipkin M, Augenlicht L. Dietary induction of colonic tumors in a mouse model of sporadic colon cancer. Cancer Res 2008; 68: 7803-7810 [PMID: 18829535 DOI: 10.1158/0008-5472. CAN-08-1209]
25. 25 Padi SK, Zhang Q, Rustum YM, Morrison C, Guo B. Mi- croRNA-627 mediates the epigenetic mechanisms of vitamin D to suppress proliferation of human colorectal cancer cells and growth of xenograft tumors in mice. Gastroenterol¬ogy 2013; 145: 437-446 [PMID: 23619147 DOI: 10.1053/ j.gastro.2013.04.012]
26. 26 Shah S, Hecht A, Pestell R, Byers SW. Trans-repression of beta-catenin activity by nuclear receptors. J Biol Chem 2003; 278: 48137-48145 [PMID: 12972427]
27. 27 Shah S, Islam MN, Dakshanamurthy S, Rizvi I, Rao M, Her- rell R, Zinser G, Valrance M, Aranda A, Moras D, Norman A, Welsh J, Byers SW. The molecular basis of vitamin D receptor and beta-catenin crossregulation. Mol Cell 2006; 21: 799-809 [PMID: 16543149]
28. 28 Burgess AW, Faux MC, Layton MJ, Ramsay RG. Wnt signal¬ing and colon tumorigenesis–– a view from the periphery. Exp Cell Res 2011; 317: 2748-2758 [PMID: 21884696 DOI: 10.1016/ j.yexcr.2011.08.010]
29. 29 Schepers A, Clevers H. Wnt signaling, stem cells, and cancer of the gastrointestinal tract. Cold Spring Harb Perspect Biol 2012; 4: a007989 [PMID: 22474007 DOI: 10.1101/cshperspect. a007989]
30. 30 Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature 2012; 487: 330-337 [PMID: 22810696 DOI: 10.1038/na- ture11252]
31. 31 Bachelder RE, Yoon SO, Franci C, de Herreros AG, Mercurio AM. Glycogen synthase kinase-3 is an endogenous inhibi¬tor of Snail transcription: implications for the epithelial- mesenchymal transition. J Cell Biol 2005; 168: 29-33 [PMID: 15631989]
32. 32 Zhou BP, Deng J, Xia W, Xu J, Li YM, Gunduz M, Hung MC. Dual regulation of Snail by GSK-3beta-mediated phosphory¬lation in control of epithelial-mesenchymal transition. Nat Cell Biol 2004; 6: 931-940 [PMID: 15448698]
33. 33 Stemmer V, de Craene B, Berx G, Behrens J. Snail promotes Wnt target gene expression and interacts with beta-catenin. Oncogene 2008; 27: 5075-5080 [PMID: 18469861]
34. 34 Kaler P, Augenlicht L, Klampfer L. Macrophage-derived IL- 1beta stimulates Wnt signaling and growth of colon cancer cells: a crosstalk interrupted by vitamin D3. Oncogene 2009; 28: 3892-3902 [PMID: 19701245 DOI: 10.1038/onc.2009.247]
35. 35 Kaler P, Galea V, Augenlicht L, Klampfer L. Tumor associ¬ated macrophages protect colon cancer cells from TRAIL- induced apoptosis through IL-1beta-dependent stabilization of Snail in tumor cells. PLoS One 2010; 5: e11700 [PMID: 20661477 DOI: 10.1371/journal.pone.0011700]
36. 36 Larriba MJ, Bonilla F, Munoz A. The transcription factors Snail1 and Snail2 repress vitamin D receptor during colon cancer progression. J Steroid Biochem Mol Biol 2010; 121: 106-109 [PMID: 20138990 DOI: 10.1016/j.jsbmb.2010.01.014]
37. 37 Larriba MJ, Martln-Villar E, Garcia JM, Pereira F, Pena C, de Herreros AG, Bonilla F, Munoz A. Snail2 cooperates with Snail1 in the repression of vitamin D receptor in colon can¬cer. Carcinogenesis 2009; 30: 1459-1468 [PMID: 19502595 DOI: 10.1093/carcin/bgp140]
38. 38 Larriba MJ, Munoz A. SNAIL vs vitamin D receptor ex¬pression in colon cancer: therapeutics implications. Br J Cancer 2005; 92: 985-989 [PMID: 15770204 DOI: 10.1038/ sj.bjc.6602484]
39. 39 Alvarez-Dlaz S, Valle N, Garcia JM, Pena C, Freije JM, Quesada V, Astudillo A, Bonilla F, Lopez-Otin C, Munoz A. Cystatin D is a candidate tumor suppressor gene induced by vitamin D in human colon cancer cells. J Clin Invest 2009; 119: 2343-2358 [PMID: 19662683]
40. 40 Larriba MJ, Gonzalez-Sancho JM, Barbachano A, Niell N, Ferrer-Mayorga G, Munoz A. Vitamin D Is a Multilevel Re-pressor of Wnt/b-Catenin Signaling in Cancer Cells. Cancers (Basel) 2013; 5: 1242-1260 [PMID: 24202444 DOI: 10.3390/ cancers5041242]
41. 41 Oyama T, Yamada Y, Hata K, Tomita H, Hirata A, Sheng H, Hara A, Aoki H, Kunisada T, Yamashita S, Mori H. Further upregulation of beta-catenin/Tcf transcription is involved in the development of macroscopic tumors in the colon of ApcMin/+ mice. Carcinogenesis 2008; 29: 666-672 [PMID: 18204079]
42. 42 Kaler P, Godasi BN, Augenlicht L, Klampfer L. The NF-kap- paB/AKT-dependent Induction of Wnt Signaling in Colon Cancer Cells by Macrophages and IL-1beta. Cancer Micro- environ 2009 Sep 25; Epub ahead of print [PMID: 19779850 DOI: 10.1007/s12307-009-0030-y]
43. 43 Vermeulen L, De Sousa E Melo F, van der Heijden M, Cam¬eron K, de Jong JH, Borovski T, Tuynman JB, Todaro M, Merz C, Rodermond H, Sprick MR, Kemper K, Richel DJ, Stassi G, Medema JP. Wnt activity defines colon cancer stem cells and is regulated by the microenvironment. Nat Cell Biol 2010; 12: 468-476 [PMID: 20418870 DOI: 10.1038/ncb2048]
44. 44 Salim T, Sand-Dejmek J, Sjolander A. The inflammatory mediator leukotriene D4 induces subcellular p-catenin translocation and migration of colon cancer cells. Exp Cell Res 2014; 321: 255-266 [PMID: 24211746 DOI: 10.1016/ j.yexcr.2013.10.021]
45. 45 Brabletz T, Jung A, Hermann K, Gunther K, Hohenberger W, Kirchner T. Nuclear overexpression of the oncoprotein beta- catenin in colorectal cancer is localized predominantly at the invasion front. Pathol Res Pract 1998; 194: 701-704 [PMID: 9820866]
46. 46 Brabletz T, Jung A, Reu S, Porzner M, Hlubek F, Kunz- Schughart LA, Knuechel R, Kirchner T. Variable beta-catenin expression in colorectal cancers indicates tumor progression driven by the tumor environment. Proc Natl Acad Sci USA 2001; 98: 10356-10361 [PMID: 11526241]
47. 47 Albini A, Sporn MB. The tumour microenvironment as a target for chemoprevention. Nat Rev Cancer 2007; 7: 139-147 [PMID: 17218951]
48. 48 Huerta S, Irwin RW, Heber D, Go VL, Koeffler HP, Us- kokovic MR, Harris DM. 1alpha,25-(OH)(2)-D(3) and its syn¬thetic analogue decrease tumor load in the Apc(min) Mouse. Cancer Res 2002; 62: 741-746 [PMID: 11830528]
49. 49 Xu H, Posner GH, Stevenson M, Campbell FC. Apc(MIN) modulation of vitamin D secosteroid growth control. Carci-nogenesis 2010; 31: 1434-1441 [PMID: 20488884 DOI: 10.1093/ carcin/bgq098]
50. 50 Larriba MJ, Ordonez-Moran P, Chicote I, Martin-Fernandez G, Puig I, Munoz A, Palmer HG. Vitamin D receptor defi-ciency enhances Wnt/p-catenin signaling and tumor burden in colon cancer. PLoS One 2011; 6: e23524 [PMID: 21858154 DOI: 10.1371/journal.pone.0023524]
51. 51 Ahearn TU, Shaukat A, Flanders WD, Rutherford RE, Bos¬tick RM. A randomized clinical trial of the effects of supple-mental calcium and vitamin D3 on the APC / p-catenin path¬way in the normal mucosa of colorectal adenoma patients. Cancer Prev Res (Phila) 2012; 5: 1247-1256 [PMID: 22964475 DOI: 10.1158/1940-6207.CAPR-12-0292]
52. 52 Itzkowitz SH, Yio X. Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflamma-tion. Am J Physiol Gastrointest Liver Physiol 2004; 287: G7-17 [PMID: 15194558]
53. 53 Oshima M, Taketo MM. COX selectivity and animal models for colon cancer. Curr Pharm Des 2002; 8: 1021-1034 [PMID: 11945149]
54. 54 Medzhitov R. Origin and physiological roles of inflam¬mation. Nature 2008; 454: 428-435 [PMID: 18650913 DOI: 10.1038/nature07201]
55. 55 Driscoll RH, Meredith SC, Sitrin M, Rosenberg IH. Vitamin D deficiency and bone disease in patients with Crohn's dis¬ease. Gastroenterology 1982; 83: 1252-1258 [PMID: 6982188]
56. 56 Liu W, Chen Y, Golan MA, Annunziata ML, Du J, Dougherty U, Kong J, Musch M, Huang Y, Pekow J, Zheng C, Bisson- nette M, Hanauer SB, Li YC. Intestinal epithelial vitamin D receptor signaling inhibits experimental colitis. J Clin Invest 2013; 123: 3983-3996 [PMID: 23945234 DOI: 10.1172/JCI65842]
57. 57 Ananthakrishnan AN, Khalili H, Higuchi LM, Bao Y, Ko- rzenik JR, Giovannucci EL, Richter JM, Fuchs CS, Chan AT. Higher predicted vitamin D status is associated with reduced risk of Crohn's disease. Gastroenterology 2012; 142: 482-489 [PMID: 22155183 DOI: 10.1053/j.gastro.2011.11.040]
58. 58 Fichera A, Little N, Dougherty U, Mustafi R, Cerda S, Li YC, Delgado J, Arora A, Campbell LK, Joseph L, Hart J, Noffs- inger A, Bissonnette M. A vitamin D analogue inhibits colon¬ic carcinogenesis in the AOM/DSS model. J Surg Res 2007; 142: 239-245 [PMID: 17574271 DOI: 10.1016/j.jss.2007.02.038]
59. 59 Chen Y, Zhang J, Ge X, Du J, Deb DK, Li YC. Vitamin D receptor inhibits nuclear factor kB activation by interacting with IkB kinase p protein. J Biol Chem 2013; 288: 19450-19458 [PMID: 23671281 DOI: 10.1074/jbc.M113.467670]
60. 60 Gounaris E, Erdman SE, Restaino C, Gurish MF, Friend DS, Gounari F, Lee DM, Zhang G, Glickman JN, Shin K, Rao VP, Poutahidis T, Weissleder R, McNagny KM, Khazaie K. Mast cells are an essential hematopoietic component for polyp development. Proc Natl Acad Sci USA 2007; 104: 19977-19982 [PMID: 18077429]
61. 61 Popivanova BK, Kitamura K, Wu Y, Kondo T, Kagaya T, Kaneko S, Oshima M, Fujii C, Mukaida N. Blocking TNF- alpha in mice reduces colorectal carcinogenesis associated with chronic colitis. J Clin Invest 2008; 118: 560-570 [PMID: 18219394]
62. 62 Rutgeerts P, Sandborn WJ, Feagan BG, Reinisch W, Olson A, Johanns J, Travers S, Rachmilewitz D, Hanauer SB, Lichten-stein GR, de Villiers WJ, Present D, Sands BE, Colombel JF. In¬fliximab for induction and maintenance therapy for ulcerative colitis. N Engl J Med 2005; 353: 2462-2476 [PMID: 16339095]
63. 63 Bessler H, Djaldetti M. 1a,25-Dihydroxyvitamin D3 modu¬lates the interaction between immune and colon cancer cells. Biomed Pharmacother 2012; 66: 428-432 [PMID: 22795808 DOI: 10.1016/j.biopha.2012.06.005]
64. 64 Sadeghi K, Wessner B, Laggner U, Ploder M, Tamandl D, Friedl J, Zugel U, Steinmeyer A, Pollak A, Roth E, Boltz- Nitulescu G, Spittler A. Vitamin D3 down-regulates mono¬cyte TLR expression and triggers hyporesponsiveness to pathogen-associated molecular patterns. Eur J Immunol 2006; 36: 361-370 [PMID: 16402404 DOI: 10.1002/eji.200425995]
65. 65 Khoo AL, Chai LY, Koenen HJ, Oosting M, Steinmeyer A, Zuegel U, Joosten I, Netea MG, van der Ven AJ. Vitamin D(3) down-regulates proinflammatory cytokine response to Mycobacterium tuberculosis through pattern recognition receptors while inducing protective cathelicidin production. Cytokine 2011; 55: 294-300 [PMID: 21592820 DOI: 10.1016/ j .cyto.2011.04.016]
66. 66 Murillo G, Nagpal V, Tiwari N, Benya RV, Mehta RG. Ac¬tions of vitamin D are mediated by the TLR4 pathway in inflammation-induced colon cancer. J Steroid Biochem Mol Biol 2010; 121: 403-407 [PMID: 20214986 DOI: 10.1016/ j.jsbmb.2010.03.009]
67. 67 Oguma K, Oshima H, Aoki M, Uchio R, Naka K, Nakamura S, Hirao A, Saya H, Taketo MM, Oshima M. Activated macrophages promote Wnt signalling through tumour ne¬crosis factor-alpha in gastric tumour cells. EMBO J 2008; 27: 1671-1681 [PMID: 18511911 DOI: 10.1038/emboj.2008.105]
68. 68 Liu Z, Brooks RS, Ciappio ED, Kim SJ, Crott JW, Bennett G, Greenberg AS, Mason JB. Diet-induced obesity elevates co¬lonic TNF-a in mice and is accompanied by an activation of Wnt signaling: a mechanism for obesity-associated colorectal cancer. J Nutr Biochem 2012; 23: 1207-1213 [PMID: 22209007 DOI: 10.1016/j.jnutbio.2011.07.002]
69. 69 Bastie CC, Gaffney-Stomberg E, Lee TW, Dhima E, Pessin JE, Augenlicht LH. Dietary cholecalciferol and calcium levels in a Western-style defined rodent diet alter energy metabo¬lism and inflammatory responses in mice. J Nutr 2012; 142: 859-865 [PMID: 22437564 DOI: 10.3945/jn.111.149914]
70. 70 Hopkins MH, Owen J, Ahearn T, Fedirko V, Flanders WD, Jones DP, Bostick RM. Effects of supplemental vitamin D and calcium on biomarkers of inflammation in colorectal adenoma patients: a randomized, controlled clinical trial. Cancer Prev Res (Phila) 2011; 4: 1645-1654 [PMID: 21724580 DOI: 10.1158/1940-6207.CAPR-11-0105]
71. 71 Skrzypczak M, Goryca K, Rubel T, Paziewska A, Mikula M, Jarosz D, Pachlewski J, Oledzki J, Ostrowski J. Model¬ing oncogenic signaling in colon tumors by multidirectional analyses of microarray data directed for maximization of analytical reliability. PLoS One 2010; 5: [PMID: 20957034 DOI: 10.1371/journal.pone.0013091]